Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Zhejiang Shouxiangu Pharmaceutical

Huaan Securities: Buy rating for Shouxiangu

  • Post date May 16, 2022 — 10:12 Post Lock Login to View

Read More

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

  • Post date May 16, 2022 — 08:44 Post Lock Login to View

Read More

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

  • Post date May 10, 2022 — 10:07 Post Lock Login to View

Read More

Institutions strongly recommend 8 stocks-Update-CFi.CN Zhongcai Network

  • Post date May 7, 2022 — 00:45 Post Lock Login to View

Read More

Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery

  • Post date May 6, 2022 — 22:37 Post Lock Login to View

Read More

The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry

  • Post date May 6, 2022 — 18:35 Post Lock Login to View

Read More

Institutions strongly recommend 2 stocks-Update-CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 16:10 Post Lock Login to View

Read More

Medicine: The new crown nucleic acid test is normalized, the economy is stabilized, and the business recovery of the leading companies in the high-prosperity track is optimistic after the epidemic period – yqqlm

  • Post date May 5, 2022 — 08:20 Post Lock Login to View

Read More

Huabao Pension ETF Net Value Gains 3.67%

  • Post date April 30, 2022 — 08:15 Post Lock Login to View

Read More

Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry

  • Post date April 24, 2022 — 15:31 Post Lock Login to View

Read More

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term.

  • Post date April 24, 2022 — 15:31 Post Lock Login to View

Read More

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term

  • Post date April 24, 2022 — 15:31 Post Lock Login to View

Read More

New Fortune Analyst Annual Meeting and High-end Capital Market Summit of Huangpu District Guangzhou Development Zone kicks off-News Channel-Hexun.com

  • Post date April 22, 2022 — 21:00 Post Lock Login to View

Read More

[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of SPDB-AXA Healthcare Hybrid A Fund_Oriental Fortune Network

  • Post date April 22, 2022 — 15:29 Post Lock Login to View

Read More

Chinese medicine can make a difference! Zuoli Pharmaceutical's performance has continuously increased significantly, and R&D investment needs to be increased.

  • Post date April 21, 2022 — 10:07 Post Lock Login to View

Read More

GF Pension Index A Net Worth Up 3.06%

  • Post date April 13, 2022 — 07:44 Post Lock Login to View

Read More

GF Pension Index C Net Worth Up 3.05%

  • Post date April 13, 2022 — 07:40 Post Lock Login to View

Read More

Huabao Pension ETF Net Value Gains 3.34%

  • Post date April 13, 2022 — 07:16 Post Lock Login to View

Read More

Southwest Securities released a research report on Shouxiangu: Q1 profit growth exceeded expectations, and expansion outside the province continued to advance – yqqlm

  • Post date April 7, 2022 — 21:03 Post Lock Login to View

Read More

Southwest Securities released a research report on Shouxiangu: Q1 profit growth exceeded expectations, and the expansion outside the province continued to advance – yqqlm

  • Post date April 7, 2022 — 21:02 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.